Pregnancy: In animal studies, nifedipine has been shown to produce embryotoxicity, foetotoxicity and teratogenicity. There are no adequate well controlled studies in pregnant women. Nifedipine should not be used during pregnancy unless the clinical condition of the woman requires treatment with nifedipine.
Lactation: The drug is not recommended for use during breastfeeding because nifedipine has been reported to be excreted in human milk and the effects of nifedipine exposure to the infant are not known.
Other Services
Country
Account